Search filters

List of works by Gisle Langslet

A phase III randomized trial evaluating alirocumab 300 mg every 4 weeks as monotherapy or add-on to statin: ODYSSEY CHOICE I.

scientific article published on 31 August 2016

Alirocumab dosing patterns during 40 months of open-label treatment in patients with heterozygous familial hypercholesterolemia

scientific article published on 30 August 2018

Cardiovascular outcomes and LDL-cholesterol levels in EMPA-REG OUTCOME<sup>®</sup>

scientific article published on 01 November 2020

Genetic testing is essential for initiating statin therapy in children with familial hypercholesterolemia: Examples from Scandinavia

scientific article published on 01 December 2020

Individualized low-density lipoprotein cholesterol reduction with alirocumab titration strategy in heterozygous familial hypercholesterolemia: Results from an open-label extension of the ODYSSEY LONG TERM trial

scientific article published on 30 November 2018

Sex differences in cholesterol levels from birth to 19 years of age may lead to increased cholesterol burden in females with FH

scientific article published on 09 March 2018

Some children with a familial hypercholesterolemia mutation may exhibit persistent low LDL levels

scientific article published on 28 June 2018

Treatment goal attainment in children with familial hypercholesterolemia: A cohort study of 302 children in Norway

scientific article published on 6 December 2017

Paulina is supported by:

About Paulina

Help